Medicaid In-Lieu-of Services: The Substitute Care Behind the Reported Cost

Whistleblower Justice Network

Medicaid in lieu of services cost reporting connects an approved substitute for covered care to a plan’s claims, encounter data and reported costs. If you work in care management, contracting, a service vendor or plan finance, you may see where those accounts stop matching. The contract names one service, the member’s file describes another, and the cost submission carries the approved label. We follow that difference back to what Medicaid paid for. When a plan reports care it never delivered, members lose the care and taxpayers fund the fiction.

In Medicaid managed care, the state usually pays the plan a fixed monthly amount for each enrolled member. The payment arrives through capitation, while the details of the care sit in other records. In-lieu-of services requirements connect a particular substitute service to those records and to the costs used in setting the plan’s payment.

What In-Lieu-of Services Replace

An in-lieu-of service or setting substitutes for care covered under the state’s Medicaid plan. It can replace that care immediately or over a longer period, or reduce or prevent the future need for it. The state must determine that the substitute is medically appropriate and cost effective, and the approved substitute must appear in the managed-care contract.

The Centers for Medicare & Medicaid Services’ managed-care rule also requires the service or setting to be eligible for approval through a state plan amendment or a home and community-based services waiver. Its use and actual cost enter the relevant capitation-rate component.

The rule names medically tailored meals and asthma remediation as possible substitutes. Meals must be fewer than three per day, and each proposed service still needs the state’s determination that it is medically appropriate and cost effective for the population it serves. For a vendor, the approved service definition matters as much as the name on an invoice.

The member keeps a choice. Declining a substitute leaves the member entitled to the covered state-plan service on the same terms, and the plan cannot use an offered or previously used substitute to deny or discourage access to that health care. For care-management staff, the account of what the member chose belongs beside the account of what the plan delivered.

What the Plan, Vendor and Finance Files Should Match

The contract must name and define each substitute, identify the covered service or setting it replaces, and specify the clinically defined population it serves. It must also describe how a licensed network provider or licensed plan staff provider determines and documents that the substitute is medically appropriate for the individual member.

The plan must use state-established codes that identify each in-lieu-of service in encounter data. Those records then help support the state’s report of the plan’s actual delivery costs. False Medicaid encounter data can therefore carry a false account of both what happened and which approved substitute it supposedly represented.

The practical comparison runs from the contract to the clinical file, the vendor’s delivery record, the encounter code and the cost submission. A vendor employee may know what was delivered. A clinician may know why the member was selected. Finance may know which costs reached the report. We put those accounts together. A reported cost should lead back to the service the state approved and the member who received it.

The May 2024 rule ties these requirements to contract rating periods beginning on or after 60 days following July 9, 2024. We match the service and report to that governing contract, including which substitute the state had approved at the time.

Which Costs Belong to Substitute Care

A plan can offer voluntary extra benefits, often called value-added services, whose costs cannot enter its capitation rate. Approved in-lieu-of services do enter rate development. For a healthcare finance employee, the classification affects which spending the state uses to set the plan’s payment.

The rule also allows approved in-lieu-of services to count as incurred claims in the medical loss ratio. Some value-added services can count there too when they meet the rule’s conditions for activities that improve health care quality. The rate submission and the medical loss ratio therefore require their own account of what the spending bought.

CMS expressly excludes third-party management, operational and infrastructure costs for ILOS from those service costs and from capitation rates. The rule also preserves restrictions on room and board. An invoice for delivering meals and a charge for building a vendor’s delivery operation raise different cost questions. We examine what the charge purchased and how the plan classified it.

What the ILOS Cost Percentages Measure

The five-percent ceiling limits the defined share of a managed-care program’s payments attributable to in-lieu-of services. It applies to both the projected and final cost percentages, which use projected and actual program payments respectively. These are program measures, not price limits on an individual vendor or member.

The actual-cost summary answers a different question: what did the plans actually spend delivering the substitutes? The state reports those costs using the claims and encounter data the plans supply. All three measures are calculated annually and certified by an actuary. The share of capitation assigned to substitute care and the cost of delivering that care remain distinct figures.

The threshold of 1.5 percent has different consequences depending on which percentage crosses it. A projected percentage above that threshold requires evidence of medical appropriateness and data supporting cost effectiveness with the contract. A final percentage above it during any of the first five authorized rating periods after the rule applies requires a retrospective evaluation. That evaluation uses five years of validated data to test costs, use and care, including whether encounter records support the state’s judgment about the substitute.

The projected percentage accompanies the annual rate certification. The final percentage and actual-cost summary arrive separately, with the rate certification for the period beginning two years after the service rating period ends. For finance staff, that lag makes the service period behind a reported cost essential to the comparison.

When a Substitute Ends, Its Costs Must Follow

CMS can require the state to terminate a substitute that no longer meets the requirements. The transition plan must address member notice and continuity of care, removal from the contract and adjustment of capitation rates as needed. For contracting and finance staff, the notice, contract amendment and revised rate certification show whether the decision to end the substitute reached the payment calculation.

When the Report Says the Care Happened

A report from Health Care Financing Administration seminars identified a basic managed-care oversight problem in 1999. Its distinction still explains why we examine the plan’s own account of spending:

One of the most basic points of confusion, reported by seminar participants, was the general failure to distinguish carefully enough between frauds committed against the Managed Care Organizations from frauds committed by the MCOs themselves.

Controlling Fraud and Abuse in Medicaid: Innovations and Obstacles, Health Care Financing Administration seminar report, 1999

The report explained that a plan has a financial incentive to challenge a provider’s false bill, while diversion of money by the plan presents a different incentive. For ILOS, that makes the link between the underlying delivery record and the plan’s reported cost worth examining. A plan checking its vendors still has to account for itself.

CareSource agreed to a $26 million settlement in 2011 to resolve allegations that it failed to deliver required screening, assessment and case management and submitted false reports to retain incentives and avoid penalties. The Justice Department’s settlement announcement reported that the whistleblowers would receive approximately $3.1 million as their share of the federal recovery. In this earlier case about required assessments, the whistleblowers alleged that nurses marked beneficiaries as assessed based on enrollment postcards:

These cards, which were rewarded with McDonald’s gift certificates, were in no way intended to be or approved as substitutes for proper Screening and Baseline Assessment.

United States ex rel. Rupert v. CareSource Management Group Co., whistleblowers’ complaint, paragraph 43

We see the absurdity in the alleged shortcut: an enrollment postcard stood in for a clinical assessment. The report credited care that the whistleblowers said never happened. For an approved substitute, the comparison is equally concrete: the defined substitute, the individual clinical decision, the actual delivery and the account sent to the state. The employee who knows how the report was assembled may be the person who can explain the difference.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Our whistleblower experts work with you to build the case around what the plan bought, what it reported and the government money behind both.

When You Know What the Plan Actually Bought

If the approved substitute, the member’s care and the reported cost tell different stories, speak with our whistleblower experts about what you see inside the plan or vendor. We build the payment story with you and bring in Medicaid managed-care whistleblower lawyers who understand clinical selection, encounter data and cost reporting. Bring us the difference you see, and we will stand beside you in pursuing your strongest Medicaid whistleblower case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365